http://www.fool.com/news/2007/01/12/big-week-at-boston-scientific.aspxBig Week at Boston ScientificBy Billy FisherJanuary 12, 2007As this week winds down, shareholders of Boston Scientific (NYSE: BSX) are feeling the karma brought on by the beginning of a new year. The company itself is looking to persevere through the adversity it faced in 2006 because of product recalls and the controversy surrounding the safety of drug-coated stents. I will have to say that the company is off to a great start so far for 2007.......
I intend to dump my GSK and buy Boston Scientific tomorrow at the market open. Zack's, Edward Jones, and Morningstar all give it strong buy recommendations, and so does the Fool. That's more than enough for me. Don't get me wrong. I love GSK, but the stock has been analyzed to death and has a fair evaluation. It may hit 60 in six months. There's more room to maneuver here, and you get 3 Boston shares for the price of every GSK share. Plus, GSK just killed a drug in clinical trials and is facing several more pesky lawsuits. The bad press won't go away.Jim
Sounds like you are selling low.
Selling low? Were you responding to my post? No. I am very, very long on BSX. They've turned the Guidant problem around. They're getting nothing but fabulous news out of the FDA, getting almost daily extensions or approvals of products. The share price is shooting up on the news. It's all been great. The 'Street' is taking notice here. The stock was strongly devalued by Fortune's article calling the Guidant acquisition the 'second worst in history,' but man, did they get a wrong number! Morningstar just came out with a five star rating and that induced me to buy.STRONG BUYJimBNorman
I meant selling GSK low. I understand you are buying into a good story for BSX it sounds also like you are bailing on a bad story for GSK. The thing I hate about making a sell and a buy simultaneously is you have to make two correct decisions back-to-back.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat